Top Markets
Coin of the day
Ortin Laboratories Limited Ortin Laboratories Limited

Ortin Laboratories Limited

ORTINLAB
Kedudukan dalam Saham #37115
Ortin Laboratories Limited, a pharmaceutical company established in Hyderabad,... Ortin Laboratories Limited, a pharmaceutical company established in Hyderabad, India, in 1986, is engaged in the manufacturing and commercialization of a diverse range of medicines, drugs, and chemical intermediates. The company provides a wide array of pharmaceutical formulations, presented as tablets, capsules, syrups, and dry powders. These products target various therapeutic domains such as metabolic diseases (e.g., anti-diabetics), allergic reactions, infections (including broad-spectrum antibiotics and antifungals like quinolones, penicillins, cephalosporins, macrolides, and antifungals), pain management and fever reduction (analgesics and antipyretics), cardiovascular ailments (anti-anginal and cardiovascular products), digestive system disorders (antacids and anti-ulcerants), neurological and psychiatric conditions (sedatives, tranquilizers, psychiatry products), and nutritional supplementation (like vitamins, calcium, iron, and protein supplements). Specialized offerings also include anti-retroviral, anti-arthritic, anti-helminthic, anti-spasmodic, gynaec, appetite stimulators, and chemotherapeutic preparations. In addition to finished pharmaceuticals, Ortin produces active pharmaceutical ingredient (API) intermediates for applications such as anti-retrovirals, anti-diabetics, pain and fever medications, antibiotics, antifungals, antacids, anti-malarials, and anti-ulcerants. Its manufacturing capabilities also extend to fine chemicals and Grignard/alkali metal compounds. The company offers specialized services covering process development and characterization, analytical research, assay development, and product characterization. It also contributes to diagnostics through the development of rapid flow kits, assays, and reagents. Ortin Laboratories undertakes long-term contracts for the production of intermediates and the creation of novel APIs. Moreover, it actively functions as a merchant exporter of its finished pharmaceutical products.
Harga Saham
$0.2488447
Disegerakkan terakhir: 2024-10-01
Modal Pasaran
$2.01M
Perubahan (1 hari)
-1.88%
Perubahan (1 tahun)
0.00%
Negara
IN
Perdagangan Ortin Laboratories Limited (ORTINLAB)

Kategori

EPS untuk Ortin Laboratories Limited (ORTINLAB)
EPS setakat June 2024 TTM: $-0.12
Menurut laporan kewangan terkini dan harga saham Ortin Laboratories Limited, EPS semasa syarikat (TTM) adalah $-0.12. Pada akhir tahun 2023, syarikat mempunyai EPS sebanyak $0.00 peningkatan berbanding EPS tahun 2022 iaitu $-0.01.
Sejarah EPS untuk Ortin Laboratories Limited dari 2008 hingga 2026
EPS pada akhir setiap tahun
Tahun EPS Ubah
2026 (TTM) $-0.12 0.33%
2024 $-0.12 11,760.00%
2023 0.00 -84.62%
2022 $-0.01 -141.14%
2021 $0.02 -271.74%
2020 $-0.01 -140.71%
2019 $0.02 75.19%
2018 $0.01 32.99%
2017 $0.01 -37.01%
2016 $0.02 -12.50%
2015 $0.02 -27.87%
2014 $0.02 -0.41%
2013 $0.02 -20.45%
2012 $0.03 -57.75%
2011 $0.07 -29.90%
2010 $0.10 49.21%
2009 $0.07 -46.67%
2008 $0.13 0.00%
EPS untuk syarikat atau pesaing yang serupa